Sponsor pipeline

Atsena Therapeutics Inc. clinical trial pipeline

Get alerts when Atsena Therapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05878860 ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis X-linked Retinoschisis Recruiting 2026-09-29
Phase 1/2
NCT03920007 Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital… Leber Congenital Amaurosis Active, Not Recruiting 2026-08-03
Get alerts when Atsena Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free